Point72 (Difc) LTD Pfizer Inc Call Options Transaction History

Point72 (Difc) LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $1.12 Million - $1.27 Million	40,600 Added 13.23%	347,400 $10.1 Billion
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $6.63 Million - $7.76 Million	262,300 Added 589.44%	306,800 $8.58 Billion
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.15 Million - $1.32 Million	44,500 New	44,500 $1.23 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 (Difc) LTD with notifications on news.